Skip to main content

Table 2 Characteristic of patients with esophageal cancer [n (%)/Mean ± SD]

From: A randomised controlled trial on roles of prostaglandin E1 nebulization among patients undergoing one lung ventilation

Characteristic

All (n = 90)

A group (n = 30)

C group (n = 30)

B group (n = 30)

P

Gender

0.627

 Male

71 (78.89)

25 (83.33)

22 (73.33)

24 (80.00)

 

 Female

19 (21.11)

5 (16.67)

8 (26.67)

6 (20.00)

 

Age, year

63.32 ± 6.46

63.20 ± 6.03

64.60 ± 5.91

62.17 ± 7.33

0.346

BMI, kg/m2

23.16 ± 2.91

22.60 ± 3.21

23.80 ± 2.55

23.08 ± 2.88

0.276

Duration of surgery, min

209.20 ± 60.92

213.53 ± 66.25

192.23 ± 36.02

221.83 ± 72.26

0.152

Duration of OLV, min

173.57 ± 50.75

177.40 ± 43.84

159.90 ± 39.30

183.40 ± 64.26

0.177

  1. BMI, Body mass index; OLV, one-lung ventilation
  2. A, 60% FiO2 + 0.1 µg/kg PGE1; B, 40% FiO2 + 0.1 µg/kg PGE1; C, 40% FiO2 + 0.2 µg/kg PGE1